ASTEX PHARMACEUTICALS INC's ticker is ASTX and the CUSIP is 04624B103. A total of 123 filers reported holding ASTEX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $548,000 | – | 133,254 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sandell Investment Services LLC | 646,089 | $5,485,000 | 4.79% |
| TIG Advisors, LLC | 3,633,592 | $30,833,000 | 3.16% |
| Sandell Asset Management Corp. | 2,107,445 | $17,892,000 | 3.10% |
| Verition Fund Management LLC | 1,818,500 | $15,421,000 | 2.33% |
| HAVENS ADVISORS LLC | 290,000 | $2,462,000 | 1.37% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 990,093 | $8,406,000 | 1.33% |
| HARVEST MANAGEMENT LLC | 125,000 | $1,061,000 | 1.14% |
| COWEN INC. | 628,972 | $5,340,000 | 0.79% |
| WATER ISLAND CAPITAL LLC | 2,291,426 | $19,431,000 | 0.75% |
| TOURADJI CAPITAL MANAGEMENT, LP | 25,000 | $212,000 | 0.65% |